Miral M. Refeat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Miral M. Refeat has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Engy A. Ashaat
Clinical Genetics Department, Human Genetics and Genome Research Institute, National Research Centre, Cairo, Egypt
3 shared publications - Khalda Sayed Amr
Division of Medical Molecular Genetics, National Research Center, Cairo, Egypt
2 shared publications - Mona O. El Ruby
Clinical Genetics Department, Human Genetics and Genome Research Institute, National Research Centre, Giza, Egypt
2 shared publications Mostafa M. El Saied
Department of Research on Children with Special Needs, Medical Research Institute, National Research Centre, Cairo, Egypt
2 shared publications- Abdel-Rahman Badr Abdel-Ghaffar
Biochemistry Department, Faculty of Science, Ain Shams University, Cairo, Egypt
1 shared publication Abeer I Abd El-Fattah
Department of Biochemistry and Molecular Biology, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo, Egypt
1 shared publication
Latest Publications
- Open Access
- 11 February 2025
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 194 (2) , 641-648
Genetic screening in cohort of Egyptian patients with pulmonary arterial hypertension disease
Background: Variants in the bone morphogenetic protein 2 receptor gene (BMPR2) are the most frequent genetic cause of pulmonary arterial hypertension (PAH). However, correlation of BMPR2 variants and PAH clinical phenotype remains to be elucidated. Methods and results: The goal of the present study is to investigate variants of the causative gene (BMPR2) in 25 Egyptian patients clinically pre-diagnosed with PAH symptoms and 10 healthy candidates using Sanger sequencing technique. Three pathogenic heterozygous missense variants have been illustrated in BMPR2 gene, two novel variants (V387E, E481K) in exon 9 and 11 respectively and one previously reported missense variant (C496G) in exon 11. The remaining 22 patients as well as the 10 healthy individuals showed no pathogenic variants. Conclusion: Further studies on larger number of participants, using advanced NGS technique, should be performed to enrich information about genotype/phenotype correlations and incidence of PAH disease among Egyptian population; thus, it would provide families of PAH patients with accurate genetic counseling in order to prevent disease recurrence.
- 11 February 2025
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 194 (2) , 641-648
Open AccessGenetic screening in cohort of Egyptian patients with pulmonary arterial hypertension disease
Background: Variants in the bone morphogenetic protein 2 receptor gene (BMPR2) are the most frequent genetic cause of pulmonary arterial hypertension (PAH). However, correlation of BMPR2 variants and PAH clinical phenotype remains to be elucidated. Methods and results: The goal of the present study is to investigate variants of the causative gene (BMPR2) in 25 Egyptian patients clinically pre-diagnosed with PAH symptoms and 10 healthy candidates using Sanger sequencing technique. Three pathogenic heterozygous missense variants have been illustrated in BMPR2 gene, two novel variants (V387E, E481K) in exon 9 and 11 respectively and one previously reported missense variant (C496G) in exon 11. The remaining 22 patients as well as the 10 healthy individuals showed no pathogenic variants. Conclusion: Further studies on larger number of participants, using advanced NGS technique, should be performed to enrich information about genotype/phenotype correlations and incidence of PAH disease among Egyptian population; thus, it would provide families of PAH patients with accurate genetic counseling in order to prevent disease recurrence.
- Open Access
- 1 January 2024
- Published by Egyptian Knowledge Bank in Azhar International Journal of Pharmaceutical and Medical Sciences
- Vol. 4 (1) , 91-97
Mutational Screening of (CLN6), (CLN7) and (CLN14) Genes in Egyptian Patients with Neuronal Ceroid Lipofuscinosis.
Neuronal ceroid lipofuscinoses (NCL), the commonest autosomal recessive neurodegenerative disorder, is marked by an accumulation of auto-fluorescent storage material, primarily in neurons. NCL affects the neurons and causes damage due to accumulation of auto-fluorescent lysosomal storage material inside the neuronal cytoplasm. Although it is a rare fatal childhood disorder, childhood, patients born with it suffer life threatening complications and disabilities that deteriorates their quality of life. The current study aims to screen for mutations in CLN 6,7, and 14 genes in twenty Egyptian patients clinically diagnosed with seizures, Retinal degeneration, progressive mental deterioration and ataxia, using direct Sanger sequencing. Two reported mutations have been detected in CLN6 gene, homozygous missense (c.299T>G) and 3-bp deletion (c.711_713delCTT) in two different cases who are not siblings, and the other eighteen patients had no genetic defects in the enrolled genes. Further studies on larger number of participants are required in order to further clarify the causative CLN genes, particularlyCLN6, CLN7 and CLN14 among Egyptian patients.
- 1 January 2024
- Published by Egyptian Knowledge Bank in Azhar International Journal of Pharmaceutical and Medical Sciences
- Vol. 4 (1) , 91-97
Open AccessMutational Screening of (CLN6), (CLN7) and (CLN14) Genes in Egyptian Patients with Neuronal Ceroid Lipofuscinosis.
Neuronal ceroid lipofuscinoses (NCL), the commonest autosomal recessive neurodegenerative disorder, is marked by an accumulation of auto-fluorescent storage material, primarily in neurons. NCL affects the neurons and causes damage due to accumulation of auto-fluorescent lysosomal storage material inside the neuronal cytoplasm. Although it is a rare fatal childhood disorder, childhood, patients born with it suffer life threatening complications and disabilities that deteriorates their quality of life. The current study aims to screen for mutations in CLN 6,7, and 14 genes in twenty Egyptian patients clinically diagnosed with seizures, Retinal degeneration, progressive mental deterioration and ataxia, using direct Sanger sequencing. Two reported mutations have been detected in CLN6 gene, homozygous missense (c.299T>G) and 3-bp deletion (c.711_713delCTT) in two different cases who are not siblings, and the other eighteen patients had no genetic defects in the enrolled genes. Further studies on larger number of participants are required in order to further clarify the causative CLN genes, particularlyCLN6, CLN7 and CLN14 among Egyptian patients.
- Open Access
- 4 May 2023
- Published by Elsevier in Journal of Taibah University Medical Sciences
- Vol. 18 (6) , 1244-1253
New drug-like small molecule antagonizes phosphatidylinositol (3,4,5)-trisphosphate (PIP3) in patients with conotruncal heart defects
- 4 May 2023
- Published by Elsevier in Journal of Taibah University Medical Sciences
- Vol. 18 (6) , 1244-1253
Open AccessNew drug-like small molecule antagonizes phosphatidylinositol (3,4,5)-trisphosphate (PIP3) in patients with conotruncal heart defects
- Open Access
- 26 November 2022
- Published by Springer Nature in neurogenetics
- Vol. 24 (1) , 17-28
Whole exome screening of neurodevelopmental regression disorders in a cohort of Egyptian patients
Developmental regression describes a child who begins to lose his previously acquired milestones skills after he has reached a certain developmental stage and though affects his childhood development. It is associated with neurodegenerative diseases including leukodystrophy and neuronal ceroid lipofuscinosis diseases (NCLs), one of the most frequent childhood-onset neurodegenerative disorders. The current study focused on screening causative genes of developmental regression diseases comprising neurodegenerative disorders in Egyptian patients using next-generation sequencing (NGS)-based analyses as well as developing checklist to support clinicians who are not familiar with these diseases. A total of 763 Egyptian children (1 to 11 years), mainly diagnosed with developmental regression, seizures, or visual impairment, were studied using whole exome sequencing (WES). Among 763 Egyptian children, 726 cases were early clinically and molecularly diagnosed, including 482 cases that had pediatric stroke, congenital infection, and hepatic encephalopathy; meanwhile, 192 had clearly dysmorphic features, 31 showed central nervous system (CNS) malformation, 17 were diagnosed by leukodystrophy, 2 had ataxia telangiectasia, and 2 were diagnosed with tuberous sclerosis. The remained 37 out of 763 candidates were suspected with NCLs symptoms; however, 28 were confirmed to be NCLs patients, 1 was Kaya-Barakat-Masson syndrome, 1 was diagnosed as infantile neuroaxonal dystrophy, and 7 cases required further molecular diagnosis. This study provided an NGS-based approach of the genetic causes of developmental regression and neurodegenerative diseases as it comprised different variants and de novo mutations with complex phenotypes of these diseases which in turn help in early diagnoses and counseling for affected families.
- 26 November 2022
- Published by Springer Nature in neurogenetics
- Vol. 24 (1) , 17-28
Open AccessWhole exome screening of neurodevelopmental regression disorders in a cohort of Egyptian patients
Developmental regression describes a child who begins to lose his previously acquired milestones skills after he has reached a certain developmental stage and though affects his childhood development. It is associated with neurodegenerative diseases including leukodystrophy and neuronal ceroid lipofuscinosis diseases (NCLs), one of the most frequent childhood-onset neurodegenerative disorders. The current study focused on screening causative genes of developmental regression diseases comprising neurodegenerative disorders in Egyptian patients using next-generation sequencing (NGS)-based analyses as well as developing checklist to support clinicians who are not familiar with these diseases. A total of 763 Egyptian children (1 to 11 years), mainly diagnosed with developmental regression, seizures, or visual impairment, were studied using whole exome sequencing (WES). Among 763 Egyptian children, 726 cases were early clinically and molecularly diagnosed, including 482 cases that had pediatric stroke, congenital infection, and hepatic encephalopathy; meanwhile, 192 had clearly dysmorphic features, 31 showed central nervous system (CNS) malformation, 17 were diagnosed by leukodystrophy, 2 had ataxia telangiectasia, and 2 were diagnosed with tuberous sclerosis. The remained 37 out of 763 candidates were suspected with NCLs symptoms; however, 28 were confirmed to be NCLs patients, 1 was Kaya-Barakat-Masson syndrome, 1 was diagnosed as infantile neuroaxonal dystrophy, and 7 cases required further molecular diagnosis. This study provided an NGS-based approach of the genetic causes of developmental regression and neurodegenerative diseases as it comprised different variants and de novo mutations with complex phenotypes of these diseases which in turn help in early diagnoses and counseling for affected families.
- Open Access
- 21 November 2022
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 192 (5) , 2265-2272
Diagnostic value of molecular approach in screening for fragile X premutation cases
Background Fragile X syndrome (FXS) is the most common form of inherited intellectual disability, caused by CGG-repeats expansion (> 200 repeats). Premutation alleles (PM) (55–200 CGG repeats) are associated with tremor ataxia syndrome (FXTAS), fragile X-associated primary ovarian insufficiency (FXPOI), and autistic problems. Aim To screen the frequency of premutation carriers using molecular diagnostic assays, in a cohort of Egyptian males with suspected clinical features of (FXS) checking for the presence of premutation alleles. Methods The current study comprised 192 Egyptian male children, 92 participants presented with intellectual disability, delayed language development, autistic-like features, behavioral difficulties, anxiety, seizures, and depression compared to 100 healthy males. All cases were subjected to clinical and neuroimaging assessments, when indicated as well as molecular analysis using methylation-specific PCR (MS-PCR) and quantitative real-time PCR (qRT-PCR). Results Thirty-four premutation carriers out of 92 Egyptian males (37%) of CGG repeats (55 to 200) were illustrated with elevated FMR1 mRNA expression level (p-value < 0.001). Additionally, 2 intermediate (IM) cases (0.03%) (45–55 CGG repeats) showed poor increase in expression level (p-value = 0.02838) plus 6 full mutation (FM) patients (0.07%) with (> 200 CGG repeats) (p-value < 0.001) resulted in FMR1 gene silence. Conclusion Molecular diagnostic assay including (MS-PCR) and (qRT-PCR) proved to be a sensitive and rapid screening tool for the detection of premutation cases. Furthermore, the presence of positive correlation between FMR1 mRNA expression levels with CGG repeats in premutation cases could serve as a potential diagnostic marker. Application of these diagnostic tools on larger number clinically suspected cases is recommended.
- 21 November 2022
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 192 (5) , 2265-2272
Open AccessDiagnostic value of molecular approach in screening for fragile X premutation cases
Background Fragile X syndrome (FXS) is the most common form of inherited intellectual disability, caused by CGG-repeats expansion (> 200 repeats). Premutation alleles (PM) (55–200 CGG repeats) are associated with tremor ataxia syndrome (FXTAS), fragile X-associated primary ovarian insufficiency (FXPOI), and autistic problems. Aim To screen the frequency of premutation carriers using molecular diagnostic assays, in a cohort of Egyptian males with suspected clinical features of (FXS) checking for the presence of premutation alleles. Methods The current study comprised 192 Egyptian male children, 92 participants presented with intellectual disability, delayed language development, autistic-like features, behavioral difficulties, anxiety, seizures, and depression compared to 100 healthy males. All cases were subjected to clinical and neuroimaging assessments, when indicated as well as molecular analysis using methylation-specific PCR (MS-PCR) and quantitative real-time PCR (qRT-PCR). Results Thirty-four premutation carriers out of 92 Egyptian males (37%) of CGG repeats (55 to 200) were illustrated with elevated FMR1 mRNA expression level (p-value < 0.001). Additionally, 2 intermediate (IM) cases (0.03%) (45–55 CGG repeats) showed poor increase in expression level (p-value = 0.02838) plus 6 full mutation (FM) patients (0.07%) with (> 200 CGG repeats) (p-value < 0.001) resulted in FMR1 gene silence. Conclusion Molecular diagnostic assay including (MS-PCR) and (qRT-PCR) proved to be a sensitive and rapid screening tool for the detection of premutation cases. Furthermore, the presence of positive correlation between FMR1 mRNA expression levels with CGG repeats in premutation cases could serve as a potential diagnostic marker. Application of these diagnostic tools on larger number clinically suspected cases is recommended.
- Open Access
- 8 August 2022
- Published by Elsevier in Journal of Genetic Engineering and Biotechnology
- Vol. 20 (1) , 117-9
Correlating SFTPC gene variants to interstitial lung disease in Egyptian children
- 8 August 2022
- Published by Elsevier in Journal of Genetic Engineering and Biotechnology
- Vol. 20 (1) , 117-9
Open AccessCorrelating SFTPC gene variants to interstitial lung disease in Egyptian children
- Open Access
- 5 October 2021
- Published by Elsevier in Journal of Genetic Engineering and Biotechnology
- Vol. 19 (1) , 147-8
Correlation of circulating miRNA-33a and miRNA-122 with lipid metabolism among Egyptian patients with metabolic syndrome
- 5 October 2021
- Published by Elsevier in Journal of Genetic Engineering and Biotechnology
- Vol. 19 (1) , 147-8
Open AccessCorrelation of circulating miRNA-33a and miRNA-122 with lipid metabolism among Egyptian patients with metabolic syndrome
- 1 May 2021
- Published by Springer Nature in Molecular Biology Reports
- Vol. 48 (5) , 4413-4420
The correlation of estrogen receptor 1 and progesterone receptor genes polymorphisms with recurrent pregnancy loss in a cohort of Egyptian women
Recurrent pregnancy loss (RPL) represents one of the pregnancy complications affecting 1–3% of women. Sex hormones, progesterone and estrogen play a critical role in the maintenance of pregnancy; they are mediated by estrogen receptor 1 (ESR1) and progesterone receptor (PR) genes respectively. Polymorphisms of (ESR1) and (PR) genes are linked to RPL. We aimed to explore the association of single nucleotide polymorphisms (SNPs) of (ESR1) gene and (PR) gene with RPL in a cohort of Egyptian population (50 infertile Egyptian women who experienced RPL and 50 healthy women), using polymerase chain reaction-restriction fragment length polymorphism analysis (PCR–RFLP) of (ESR1) gene and DNA sequencing of exons 1 and 5 of (PR) gene. Genotyping of ESR1 gene SNP’s: (rs2234693) and (rs9340799) revealed higher significance in cases compared to controls of p value (p = 0.006 and p = 0.001) respectively. However, the frequencies of the two variants in (PG) gene; S344T (rs3740753) (p = 0.0001) and H770H (rs1042839) (p = 0.001) were significantly higher in women compared to the healthy control women. New polymorphism P352Q was observed in 2% of cases (p = 0.0001). There was a significant association of SNP’s of ESR1 and PR genes with recurrent pregnancy loss RPL. Further demographics studies should be carried on a larger number of women at risk of recurrent implantation to elucidate this SNP’s association and its role in RPL women.
- 1 May 2021
- Published by Springer Nature in Molecular Biology Reports
- Vol. 48 (5) , 4413-4420
The correlation of estrogen receptor 1 and progesterone receptor genes polymorphisms with recurrent pregnancy loss in a cohort of Egyptian women
Recurrent pregnancy loss (RPL) represents one of the pregnancy complications affecting 1–3% of women. Sex hormones, progesterone and estrogen play a critical role in the maintenance of pregnancy; they are mediated by estrogen receptor 1 (ESR1) and progesterone receptor (PR) genes respectively. Polymorphisms of (ESR1) and (PR) genes are linked to RPL. We aimed to explore the association of single nucleotide polymorphisms (SNPs) of (ESR1) gene and (PR) gene with RPL in a cohort of Egyptian population (50 infertile Egyptian women who experienced RPL and 50 healthy women), using polymerase chain reaction-restriction fragment length polymorphism analysis (PCR–RFLP) of (ESR1) gene and DNA sequencing of exons 1 and 5 of (PR) gene. Genotyping of ESR1 gene SNP’s: (rs2234693) and (rs9340799) revealed higher significance in cases compared to controls of p value (p = 0.006 and p = 0.001) respectively. However, the frequencies of the two variants in (PG) gene; S344T (rs3740753) (p = 0.0001) and H770H (rs1042839) (p = 0.001) were significantly higher in women compared to the healthy control women. New polymorphism P352Q was observed in 2% of cases (p = 0.0001). There was a significant association of SNP’s of ESR1 and PR genes with recurrent pregnancy loss RPL. Further demographics studies should be carried on a larger number of women at risk of recurrent implantation to elucidate this SNP’s association and its role in RPL women.